Análisis de la utilización de inhibidores de la bomba de protones en Atención Primaria / Analysis of the use of proton pump inhibitors in primary health care

Objetivo: El incremento en el consumo de antiulcerosos se acompaña de una elevada tasa de utilización incorrecta. Los objetivos del estudio fueron analizar la adecuación de la prescripción crónica de inhibidores de la bomba de protones (IBP) en un centro de salud, así como la eficacia de una intervención de mejora. Material y métodos: Estudio descriptivo transversal y observacional de prevalencia que incluyó a pacientes de un centro de salud en tratamiento con IBP durante, al menos, 3meses consecutivos (de noviembre de 2016 a enero de 2017). Se analizó la indicación, posología y duración de tratamiento del IBP, interacciones farmacológicas y posibles riesgos que pudieran relacionarse con el uso continuado de IBP. Se realizó una intervención para optimizar la prescripción racional y eficiente de estos fármacos. Resultados: Se incluyó a 703 pacientes, lo que supone el 5,4% sobre el total de los pacientes mayores de edad adscritos al centro. De ellos, 436 (62,0%) no presentaban criterios de adecuación; el 52,5% eran mujeres, el 70,0% mayores de 65 años y llevaban una media de 2,7 ± 1,9 años en tratamiento. El 48,1% presentaban interacciones y el 29,0%, algún factor de riesgo. Tras la intervención se corrigió la prescripción inadecuada a 112 pacientes (25,7%), que se redujo al 46,1% (p < 0,001). Conclusiones: Existe una elevada prevalencia de prescripción e inadecuación de IBP a largo plazo, por lo que resulta necesario mejorar la formación de los profesionales para potenciar su uso racional y reducir los riesgos. La puesta en marcha de un programa de intervención ha permitido revisar y optimizar los tratamientos

Objective: The increase in the consumption of anti-ulcer drugs is accompanied by a high rate of incorrect use. The objectives of this study were to analyse the adequacy of repeat prescriptions of proton pump inhibitors (PPIs) in a Medical Centre, and to evaluate the efficacy of an improvement intervention. Material and method: A cross-sectional, descriptive and observational study of prevalence was conducted on patients in a medical centre under treatment with PPIs for at least 3consecutive months (November 2016-January 2017). An analysis was performed that included the indication, dosage and time of treatment with PPIs, drug interactions, and possible risks that could be related with their use. An intervention was carried out to optimise rational and efficient prescribing of these medicines. Results: A total of 703 patients were included in the study, which is 5.4% of the total adult patients that are assigned to the centre. Adequacy criteria were not met by 436 (62.0%). Of these, 52.5% were women, 70.0% were over 65 years old, and had been on treatment for a mean of 2.7 ± 1.9 years. Interactions were observed in 48.1%, and 29.0% had some risk factors. After the intervention, the inadequate prescribing was corrected in 112 (25.7%) patients, which was a reduction of 46.1% (P<.001). Conclusions: There is a high prevalence of prescription and inadequacy of PPIs in the long term. This suggests that it is necessary to improve training of professionals to strengthen rational use and to reduce risks. The launch of an intervention programme has led to the revision and optimisation of treatments

[Analysis of the use of proton pump inhibitors in primary health care]. / Análisis de la utilización de inhibidores de la bomba de protones en Atención Primaria.

OBJECTIVE: The increase in the consumption of anti-ulcer drugs is accompanied by a high rate of incorrect use. The objectives of this study were to analyse the adequacy of repeat prescriptions of proton pump inhibitors (PPIs) in a Medical Centre, and to evaluate the efficacy of an improvement intervention. MATERIAL AND METHOD: A cross-sectional, descriptive and observational study of prevalence was conducted on patients in a medical centre under treatment with PPIs for at least 3consecutive months (November 2016-January 2017). An analysis was performed that included the indication, dosage and time of treatment with PPIs, drug interactions, and possible risks that could be related with their use. An intervention was carried out to optimise rational and efficient prescribing of these medicines. RESULTS: A total of 703 patients were included in the study, which is 5.4% of the total adult patients that are assigned to the centre. Adequacy criteria were not met by 436 (62.0%). Of these, 52.5% were women, 70.0% were over 65 years old, and had been on treatment for a mean of 2.7 ± 1.9 years. Interactions were observed in 48.1%, and 29.0% had some risk factors. After the intervention, the inadequate prescribing was corrected in 112 (25.7%) patients, which was a reduction of 46.1% (P<.001). CONCLUSIONS: There is a high prevalence of prescription and inadequacy of PPIs in the long term. This suggests that it is necessary to improve training of professionals to strengthen rational use and to reduce risks. The launch of an intervention programme has led to the revision and optimisation of treatments.